论文部分内容阅读
恶性血液病患者临床上常伴有止血功能紊乱，表现为不同程度的出血倾向，其机制较为复杂。对此我们检测了44例恶性血液病患者血浆抗凝血酶三（＊T巨：C）、见因子（w：c）和纤溶酶原活性（PLg），结果如下。l材料与方法1．1一般资料所有病例均为住院患者，其中经血及骨赢细胞形
Patients with hematological malignancies are often accompanied by hemostasis in clinical practice, manifested as different degrees of bleeding tendency, and its mechanism is more complicated. In this regard, we tested plasma antithrombin III (*T giant:C), factor (w:c), and plasminogen activity (PLg) in 44 patients with hematologic malignancies. The results are as follows. l Materials and methods 1.1 General information All cases are hospitalized patients, including menstrual blood and bone to win cell shape